Pubblicazioni

  1. Calvaruso M, Gulino A, Buffa S, Guarnotta C, Franco G, Cacciatore M, Bonura MG, Franco V, Florena AM. Challenges and new prospects in Hepatosplenic γδ T-cell lymphoma. Leuk Lymphoma. 2014 Mar 10:1-9.
  2. Franco G, Guarnotta C, Frossi B, Piccaluga PP, Boveri E, Gulino A, Fuligni F, Rigoni A, Porcasi R, Buffa S, Betto E, Florena AM, Franco V, Iannitto E, Arcaini L, Pileri SA, Pucillo C, Colombo MP, Sangaletti S, Tripodo C. Bone marrow stroma CD40 expression correlates with inflammatory mast cell infiltration and disease progression in splenic marginal zone lymphoma. Blood. 2014 Mar 20;123(12):1836-49.
  3. Mancuso S, Franco G, Iannitto E, Saccullo G, Napolitano M, DiPiazza F, Siragusa S. Pneumocystis jiroveci pneumonia in hematological patients: our experience. Haematologica 2013;98(s3):117. Abstract n.P153
  4. Raso S, Franco G, Bono R, Quintini G, Lipari MG, Mitra ME, Mancuso S, Siragusa S. Absolute lymphocyte and monocyte count at diagnosis predicts overall survival in patients with plasma cell myeloma treated with bortezomib. Haematologica 2013;98(s3):145. Abstract n.P229
  5. Tripodo C, Sangaletti S, Guarnotta C, Piccaluga PP, Cacciatore M, Giuliano M,  Franco G, Chiodoni C, Sciandra M, Miotti S, Calvaruso G, Carè A, Florena AM, Scotlandi K, Orazi A, Pileri SA, Colombo MP. Stromal SPARC contributes to the detrimental fibrotic changes associated with myeloproliferation whereas its deficiency favors myeloid cell expansion. Blood. 2012 Oct 25;120(17):3541-54.
  6. Rizzo C, Rizzo S, Scirè E, Di Bona D, Ingrassia C, Franco G, Bono R, Quintini  G, Caruso C. Thrombotic thrombocytopenic purpura: a review of the literature in the light of our experience with plasma exchange. Blood Transfus. 2012 Jun 27:1-12.
  7. S Mancuso, G Franco, A Augello, G Iovine, G Saccullo, V Abbadessa, S Siragusa. Pneumocystis jiroveci pneumonia in hematological patients: a single institution experience. Haematologica 2012; 97(s1):176. Abstract n.438
  8. M Mitra, M Fadda, V Abbadessa, M Norata, R Bono, G Iovino, G Franco. Prognostic role of immunophenotyping in acute myeloid leukemia. Haematologica2012; 97(s1):500. Abstract n.1215
  9. Franco G, Sangaletti S, Guarnotta C, Frossi B, Iannitto E, Calvaruso M, Colombo M, Tripodo C. Bone marrow stroma CD40 expression in splenic marginal zone lymphoma is associated with prominent mast cell infiltration and correlates with shorter time to progression. Haematologica. 2011 Jun;96(s2):144. Abstract n.0346 
  10. Tripodo C, Sangaletti S, Piccaluga PP, Prakash S, Franco G, Borrello I, Orazi  A, Colombo MP, Pileri SA. The bone marrow stroma in hematological neoplasms-a guilty bystander. Nat Rev Clin Oncol. 2011 Mar 29;8(8):456-66.
  1. Iannitto E, Morabito F, Mancuso S, Gentile M, Montanini A, Augello A, Bongarzoni V, D’Arco A, Di Renzo N, Fazzi R, Franco G, Marasca R, Mulè A, Musso M, Musto P, Pennese E, Piccin A, Rota-Scalabrini D, Visani G, Rigacci L. Bendamustine with or without rituximab in the treatment of relapsed chronic lymphocytic leukaemia: an Italian retrospective study. Br J Haematol. 2011 May;153(3):351-357.
  2. Tripodo C, Gri G, Piccaluga PP, Frossi B, Guarnotta C, Piconese S, Franco G, Vetri V, Pucillo CE, Florena AM, Colombo MP, Pileri SA. Mast cells and Th17 cells contribute to the lymphoma-associated pro-inflammatory microenvironment of angioimmunoblastic T-cell lymphoma. Am J Pathol. 2010 Aug;177(2):792-802. 
  3. Franco G, Palazzolo R, Liardo E, Tripodo C, Mancuso S. T cell large granular lymphocytic leukemia in association with Sjögren’s syndrome. Acta Haematol. 2010;124(1):5-8.
  4. Di Bernardo A, Macor P, Guarnotta C, Franco G, Florena AM, Tedesco F, Tripodo  C. Humoral immunotherapy of multiple myeloma: perspectives and perplexities. Expert Opin Biol Ther. 2010 Jun;10(6):863-73.
  5. E Iannitto, F Morabito, S Mancuso, M Gentile, A Augello, V Bongarzoni, N Cascavilla, A D’Arco, N Di Renzo, R Fazzi, F Ferrara, G Franco, M Gobbi, E Liardo, AM Liberati, R Marasca, A Montanini, A Mulè, M Musso, P Musto, E Pennese, A Piccin, D Rota Scalabrini, M Sciacca, G Visani, V Abbadessa, L Rigacci. Bendamustine (B) in combination with rituximab (R) for patients with relapsed/resistant chronic lymphocytic leukemia (CLL): an italian multicentre retrospective study. Haematologica. 2010 Jun;95(s2):323, Abstract n.0774
  6. E Iannitto, S Mancuso, A Augello, G Franco, E Domingo-Domenech, E Pennese, V Vincenzo. Bendamustine in association with rituximab as salvage therapy for splenic marginal zone lymphoma. Haematologica. 2010 Jun;95(s2):524, Abstract n.1287
  1. Tripodo C, Di Bernardo A, Ternullo MP, Guarnotta C, Porcasi R, Ingrao S, Gianelli U, Boveri E, Iannitto E, Franco G, Florena AM. CD146(+) bone marrow osteoprogenitors increase in the advanced stages of primary myelofibrosis. Haematologica. 2009 Jan;94(1):127-30.
  2. Iannitto E., Minardi V., Barone R, Cascavilla N., Caracciolo C., Di Raimondo F, Ferrara F.,  Franco G., Liardo E., Mancuso S., Martino B., Mazza P., Mugolino C., Musso M., Musto P., Pagnucco G., Palmieri F., Russo-Rossi A., Specchia G., Turri D., Abbadessa V. Chronic myeloid leukemia as second malignancy; a retrospective multicentric study. Haematologica. 2009 Oct;94(s4):42, Abstract n.C-084
  3. Mancuso S., Liardo E., Augello A., Franco G., Iannitto E., Florena A. Lymphonodal amyloidosis: case report. Haematologica. 2009 Oct;94(s4):248, Abstract n.PU-100
  4. Iannitto E., Luminari S., Mammi C., Minardi V., Merli F., Angrilli F., Stelitano C., Cesaretti M., Franco G., Carella A.M., Federico M. Non-pegylated lyposomal doxorubicin, cyclophosphamide, vincristine, prednisone, and rituximab (R-COMP) as initial treatment for patients with splenic marginal zone lymphoma (SMZL): A GISL study. Haematologica 2007; 92(s3):185. Abstract n.PO-361.
  5. Minardi V, Tripodo C, Franco G, Iannitto E. Treatment of myelomatous pleural effusion with intrapleural bortezomib. A case report. Haematologica 2007; 92(s3):216. Abstract n.PU-049.